Hemab Therapeutics Holdings, Inc. (COAG) Stock Research

Over a week ago

Hemab Therapeutics presents sutacimig data at ISTH Congress

COAG

Jul 14, 7:50 AM

Hemab Therapeutics price target raised by $8 at Jefferies, here's why

Jul 13, 8:52 AM

Hemab Therapeutics price target raised by $13 at Wedbush, here's why

COAG

Jul 13, 8:08 AM

Hemab Therapeutics price target raised by $12 at H.C. Wainwright, here's why

COAG

Jul 13, 6:05 AM

Hemab Therapeutics presents new clinical data from HMB-002 in VWD

COAG

Jul 12, 9:42 AM

Hemab Therapeutics initiated with bullish view at H.C. Wainwright, here's why

COAG

Jun 17, 6:01 AM

Jefferies sees positive readthroughs to Hemab Therapeutics from Incyte deal

Jun 8, 1:57 PM

Opening Day: SpaceX submits S-1 for Nasdaq IPO

+15

May 26, 11:02 AM

Wedbush bullish on Hemab Therapeutics, initiates with an Outperform

COAG

May 26, 8:55 AM

Hemab Therapeutics initiated with bullish view at Evercore ISI, here's why

COAG

May 26, 8:39 AM

Hemab Therapeutics initiated with bullish view at Wedbush

COAG

May 26, 7:02 AM

Hemab Therapeutics initiated with bullish view at Jefferies, here's why

COAG

May 26, 5:11 AM

Hemab Therapeutics initiated with bullish view at Goldman Sachs, here's why

COAG

May 26, 4:24 AM

Opening Day: Pershing Square listings open soft in market debut

+17

May 4, 11:46 AM

Hemab Therapeutics opens at $27, IPO priced at $18 per share

COAG

May 1, 12:31 PM

Hemab Therapeutics 16.75M share IPO priced at $18.00

COAG

Apr 30, 7:01 PM

Hemab Therapeutics 15M share IPO price range $16.00-$18.00

COAG

Apr 30, 10:18 AM

Hemab Therapeutics 11.76M share IPO price range $16.00-$18.00

COAG

Apr 27, 10:10 AM

No more stories

Charts